Ahmet Can Berkyurek

Dr. Berkyurek is the co-founder and Chief Executive Officer (CEO) of Cambridge Medixine (CamMed), and completed M.Sc. and Ph.D. degrees at Osaka University with a research fellowship from the Japanese Government, and a B.Sc. degree from Istanbul Technical University (ITU). Dr. Berkyurek continued his scientific career at the University of Cambridge as a research fellow with a Marie-Curie Fellowship in the area of RNA Biology, and worked in the biotech industry at the intersection of biochemistry, cell biology, RNA biology, oligonucleotide and vaccine/RNA therapeutics. Dr. Berkyurek has been nominated as a finalist in the category of Researcher of the Year 2023 by Cambridge Independent Science and Technology Awards for his discoveries in RNA therapeutics to prevent SARS-CoV-2 infections.